Vanguard Portfolio Management
CLPT icon

Vanguard Portfolio Management’s ClearPoint Neuro CLPT Stock Holding History

Vanguard Portfolio Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.47M Sell
194,584
-90,225
-32% -$1.13M ﹤0.01% 2548
2026
Q1 		$2.59M Buy
+284,809
New +$3.6M ﹤0.01% 2526

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Vanguard Portfolio Management's CLPT Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its ClearPoint Neuro (CLPT) stake by 32% in Q2 2026, selling an estimated $1.13M and leaving 194,584 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2548.

Vanguard Portfolio Management first reported a position in CLPT in Q1 2026 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Vanguard Portfolio Management held 194,584 shares of ClearPoint Neuro worth $3.47M as of Q2 2026.
  • Vanguard Portfolio Management sold 90,225 ClearPoint Neuro shares in Q2 2026, an estimated $1.13M.
  • ClearPoint Neuro made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2548 holding.
  • Vanguard Portfolio Management first reported a position in ClearPoint Neuro in Q1 2026 and has held it in 2 quarters since.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.